The Congo virus, also known as Crimean-Congo hemorrhagic fever (CCHF) virus, causes Crimean-Congo hemorrhagic fever. CCHF is a severe tick-borne viral disease that can cause severe and often fatal illness.
- Transmission: The virus is primarily transmitted to humans through the bite of an infected tick, particularly ticks of the genus Hyalomma. It can also be transmitted through contact with infected animal blood, tissues, or bodily fluids.
- Incubation period: Usually 2 to 7 days, rarely extending up to 13 days.
- Initial symptoms: Fever, chills, headache, muscle aches, joint pain, nausea, and vomiting. These are common to many viral infections, making early diagnosis difficult.
- Hemorrhagic phase: After a few days, the disease can progress to severe bleeding from the nose, gums, gastrointestinal tract, and under the skin, causing bruising. Bleeding can be severe and lead to life-threatening complications.
- Multiple organ failure: In severe cases, CCHF can lead to failure of the liver, kidneys, lungs, and central nervous system. Liver damage can cause jaundice; kidney failure can lead to waste accumulation.
- Complications and mortality: CCHF can be fatal in up to 40% of cases if not treated promptly. Risk is higher among those with underlying medical conditions or weakened immune systems.
- Treatment: There is no specific antiviral treatment. Treatment is mainly supportive, including intravenous fluids, blood transfusions, respiratory support, and medications to control bleeding and prevent infection.
- Prevention: Focuses on avoiding tick bites and contact with infected animals through repellents, protective clothing, and precautions when handling animals. Vaccination is available in some endemic countries but not widely globally.